Transforming growth factor-beta-3

Drug Profile

Transforming growth factor-beta-3

Alternative Names: CGP-46614; TGF-β3

Latest Information Update: 21 Feb 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OSI Pharmaceuticals
  • Class Antineoplastics; Growth factors; Transforming growth factors
  • Mechanism of Action Transforming growth factor beta3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Female infertility; Wounds
  • Discontinued Chronic wounds; Stomatitis

Most Recent Events

  • 21 Feb 2007 No development reported - Preclinical for Female infertility (unspecified route)
  • 21 Feb 2007 No development reported - Preclinical for Wounds in United Kingdom (Topical)
  • 03 Dec 2001 Preclinical trials in Female infertility (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top